Drug Discovery & Pharmaceuticals

RSS

Pharmaceutical researchers aim to create better CBD-like treatments

Cannabidiol (CBD) is an increasingly popular wellness trend. The compound, which occurs naturally in cannabis plants, is added to many products that claim to reduce anxiety, alleviate pain and more, without the intoxication of its cousin tetrahydrocannabinol (THC).

2 Sep 2020

Cannabis-impaired driving among topics to be addressed at forensic toxicology nonprofit’s first virtual event

The Society of Forensic Toxicologists will host SOFTember, its virtual event in lieu of its annual meeting, which would have celebrated its 50th anniversary.

1 Sep 2020

Thomas Jefferson University receives grant for the development of CoraVax

The Commonwealth of Pennsylvania has announced grants totaling $10M to 23 entities to develop effective COVID-19 vaccines, treatments and therapies.

28 Aug 2020

Bulky benchtops for fingerprinting drugs could be replaced with a tiny photonic chip

As new infectious diseases emerge and spread, one of the best shots against novel pathogens is finding new medicines or vaccines.

28 Aug 2020

SARS discovery boots search for COVID-19 drugs

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.

27 Aug 2020

Dotmatics announces the launch of Bioregister 2020.1

Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of Bioregister 2020.1, the latest version of its web-based application for registering sequence-based, chemically modified and structure-less biological entities.

27 Aug 2020

Accidental discovery of new antibiotic proven effective after several experiments

It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.

24 Aug 2020

The Native Antigen Company announces custom contract service to develop influenza A and B antigens

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses.

21 Aug 2020

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fastest and safest methods, as the drugs are already being used to treat other conditions therefore leading to fewer chances of adverse reactions.

21 Aug 2020

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

Cobra Biologics, part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and CombiGene AB, the leading gene therapy company in the Nordic region, today announced that Cobra has successfully produced master cell banks for the three plasmids used as starting material for CombiGene’s gene therapy CG01.

21 Aug 2020

CUNY School of Medicine and TechnoVax announce COVID-19 vaccine breakthrough

The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19.

19 Aug 2020

CARE consortium launches to accelerate drug discovery and development for COVID-19

CARE a new consortium supported by the Innovative Medicines Initiative public-private partnership announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.

19 Aug 2020

Biotechnological production of a natural antibiotic

Thomas Brück saw the sea whip Antillogorgia elisabethae for the first time 17 years ago while diving on a research trip to the Bahamas.

17 Aug 2020

Studying the Proteome and Human Diseases using Mass Spectrometry

An interview with Amanda Hummon, discussing how mass spectrometry can be used to analyze the proteome and how this can help with the study of human disease.

From Pittcon 13 Aug 2020

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

Rice University scientists have won federal support for their pursuit of novel drugs to treat human disease.

10 Aug 2020

New platform shows potential to generate most effective vaccines with fewest side effects

The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to generate the most effective vaccines with the fewest side effects.

7 Aug 2020

Drug Discovery & Pharmaceuticals

Pharmaceutical researchers aim to create better CBD-like treatments

Cannabis-impaired driving among topics to be addressed at forensic toxicology nonprofit’s first virtual event

Thomas Jefferson University receives grant for the development of CoraVax

Bulky benchtops for fingerprinting drugs could be replaced with a tiny photonic chip

SARS discovery boots search for COVID-19 drugs

Dotmatics announces the launch of Bioregister 2020.1

Accidental discovery of new antibiotic proven effective after several experiments

The Native Antigen Company announces custom contract service to develop influenza A and B antigens

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

CUNY School of Medicine and TechnoVax announce COVID-19 vaccine breakthrough

CARE consortium launches to accelerate drug discovery and development for COVID-19

Biotechnological production of a natural antibiotic

Studying the Proteome and Human Diseases using Mass Spectrometry

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

New platform shows potential to generate most effective vaccines with fewest side effects

New process could fast track antiviral and anticancer drug discovery

Chemists discover a way to create synthetic version of natural anti-cancer compound

First DEA-registered hemp analytical testing lab in Texas

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News